Cargando…

Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patients

Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue and 90% of cases are due to dominant mutations in COL1A1 and COL1A2 genes. To increase OI disease knowledge and contribute to patient follow-up management, a homogeneous Italian cohort of 364 subjects affected by OI typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Maioli, Margherita, Gnoli, Maria, Boarini, Manila, Tremosini, Morena, Zambrano, Anna, Pedrini, Elena, Mordenti, Marina, Corsini, Serena, D’Eufemia, Patrizia, Versacci, Paolo, Celli, Mauro, Sangiorgi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777444/
https://www.ncbi.nlm.nih.gov/pubmed/30886339
http://dx.doi.org/10.1038/s41431-019-0373-x
_version_ 1783456632750997504
author Maioli, Margherita
Gnoli, Maria
Boarini, Manila
Tremosini, Morena
Zambrano, Anna
Pedrini, Elena
Mordenti, Marina
Corsini, Serena
D’Eufemia, Patrizia
Versacci, Paolo
Celli, Mauro
Sangiorgi, Luca
author_facet Maioli, Margherita
Gnoli, Maria
Boarini, Manila
Tremosini, Morena
Zambrano, Anna
Pedrini, Elena
Mordenti, Marina
Corsini, Serena
D’Eufemia, Patrizia
Versacci, Paolo
Celli, Mauro
Sangiorgi, Luca
author_sort Maioli, Margherita
collection PubMed
description Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue and 90% of cases are due to dominant mutations in COL1A1 and COL1A2 genes. To increase OI disease knowledge and contribute to patient follow-up management, a homogeneous Italian cohort of 364 subjects affected by OI types I–IV was evaluated. The study population was composed of 262 OI type I, 24 type II, 39 type III, and 39 type IV patients. Three hundred and nine subjects had a type I collagen affecting function mutations (230 in α1(I) and 79 in α2(I)); no disease-causing changes were noticed in 55 patients. Compared with previous genotype–phenotype OI correlation studies, additional observations arose: a new effect for α1- and α2-serine substitutions has been pointed out and heart defects, never considered before, resulted associated to quantitative mutations (P = 0.043). Moreover, some different findings emerged if compared with previous literature; especially, focusing the attention on the lethal form, no association with specific collagen regions was found and most of variants localized in the previously reported “lethal clusters” were causative of OI types I–IV. Some discrepancies have been highlighted also considering the “50–55 nucleotides rule,” as well as the relationship between specific collagen I mutated region and the presence of dentinogenesis imperfecta and/or blue sclera. Despite difficulties still present in defining clear rules to predict the clinical outcome in OI patients, this study provides new pieces for completing the puzzle, also thanks to the inclusion of clinical signs never considered before and to the large number of OI Italian patients.
format Online
Article
Text
id pubmed-6777444
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-67774442019-10-07 Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patients Maioli, Margherita Gnoli, Maria Boarini, Manila Tremosini, Morena Zambrano, Anna Pedrini, Elena Mordenti, Marina Corsini, Serena D’Eufemia, Patrizia Versacci, Paolo Celli, Mauro Sangiorgi, Luca Eur J Hum Genet Article Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue and 90% of cases are due to dominant mutations in COL1A1 and COL1A2 genes. To increase OI disease knowledge and contribute to patient follow-up management, a homogeneous Italian cohort of 364 subjects affected by OI types I–IV was evaluated. The study population was composed of 262 OI type I, 24 type II, 39 type III, and 39 type IV patients. Three hundred and nine subjects had a type I collagen affecting function mutations (230 in α1(I) and 79 in α2(I)); no disease-causing changes were noticed in 55 patients. Compared with previous genotype–phenotype OI correlation studies, additional observations arose: a new effect for α1- and α2-serine substitutions has been pointed out and heart defects, never considered before, resulted associated to quantitative mutations (P = 0.043). Moreover, some different findings emerged if compared with previous literature; especially, focusing the attention on the lethal form, no association with specific collagen regions was found and most of variants localized in the previously reported “lethal clusters” were causative of OI types I–IV. Some discrepancies have been highlighted also considering the “50–55 nucleotides rule,” as well as the relationship between specific collagen I mutated region and the presence of dentinogenesis imperfecta and/or blue sclera. Despite difficulties still present in defining clear rules to predict the clinical outcome in OI patients, this study provides new pieces for completing the puzzle, also thanks to the inclusion of clinical signs never considered before and to the large number of OI Italian patients. Springer International Publishing 2019-03-18 2019-07 /pmc/articles/PMC6777444/ /pubmed/30886339 http://dx.doi.org/10.1038/s41431-019-0373-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Maioli, Margherita
Gnoli, Maria
Boarini, Manila
Tremosini, Morena
Zambrano, Anna
Pedrini, Elena
Mordenti, Marina
Corsini, Serena
D’Eufemia, Patrizia
Versacci, Paolo
Celli, Mauro
Sangiorgi, Luca
Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patients
title Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patients
title_full Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patients
title_fullStr Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patients
title_full_unstemmed Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patients
title_short Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patients
title_sort genotype–phenotype correlation study in 364 osteogenesis imperfecta italian patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777444/
https://www.ncbi.nlm.nih.gov/pubmed/30886339
http://dx.doi.org/10.1038/s41431-019-0373-x
work_keys_str_mv AT maiolimargherita genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT gnolimaria genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT boarinimanila genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT tremosinimorena genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT zambranoanna genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT pedrinielena genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT mordentimarina genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT corsiniserena genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT deufemiapatrizia genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT versaccipaolo genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT cellimauro genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients
AT sangiorgiluca genotypephenotypecorrelationstudyin364osteogenesisimperfectaitalianpatients